YAP expression levels are positively correlated with TEAD4 (the c-terminal region of transcriptional enhancer factor TEF-1) levels [60] and their co-expression is a prognostic marker for poor ovarian cancer survival [59]. This evidence concerns the gene TEAD1 and ovarian cancer.